Coronavirus: Johnson & Johnson receive $1 billion from U.S. government as vaccine trial underway

Johnson & Johnson and Beth Israel Deaconess in Boston has received US$1 billion from the U.S. government for 100 million of its COVID-19 vaccine as the collaboration is one of more than 20 vaccine trials taking place.

• Johnson & Johnson’s single-dose COVID-19 vaccine candidate begins phase 3 trial
• Coronavirus: Mexico to conduct phase 3 trials for China, U.S. vaccine candidates